Baseline cerebrospinal fluid biomarkers of amyloidosis, phosphorylated tau, and total tau relate to greater longitudinal atrophy in regions susceptible to Alzheimer's disease‐related neurodegeneration: Biomarkers (non&#8208...

MLA

Moore, Elizabeth E., et al. “Baseline Cerebrospinal Fluid Biomarkers of Amyloidosis, Phosphorylated Tau, and Total Tau Relate to Greater Longitudinal Atrophy in Regions Susceptible to Alzheimer’s Disease‐related Neurodegeneration: Biomarkers (Non‐..” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, vol. 16, no. 11, Dec. 2020, pp. 1–2. EBSCOhost, https://doi.org/10.1002/alz.046095.

APA

Moore, E. E., Khan, O. A., Liu, D., Pechman, K. R., Acosta, L. M. Y., Bell, S. P., Landman, B. A., Blennow, K., Zetterberg, H., Hohman, T. J., Gifford, K. A., & Jefferson, A. L. (2020). Baseline cerebrospinal fluid biomarkers of amyloidosis, phosphorylated tau, and total tau relate to greater longitudinal atrophy in regions susceptible to Alzheimer’s disease‐related neurodegeneration: Biomarkers (non‐.. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 16(11), 1–2. https://doi.org/10.1002/alz.046095

Chicago

Moore, Elizabeth E., Omair A. Khan, Dandan Liu, Kimberly R. Pechman, Lealani Mae Y. Acosta, Susan P. Bell, Bennett A. Landman, et al. 2020. “Baseline Cerebrospinal Fluid Biomarkers of Amyloidosis, Phosphorylated Tau, and Total Tau Relate to Greater Longitudinal Atrophy in Regions Susceptible to Alzheimer’s Disease‐related Neurodegeneration: Biomarkers (Non‐..” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 16 (11): 1–2. doi:10.1002/alz.046095.